In the article that accompanies this editorial, Bergstrom et al 7 present DeepHRD, a deep learning (DL) algorithm that predicts homologous recombination deficiency and clinical outcomes directly from ...

Prostate cancer (PCa) represents a highly heterogeneous disease that requires tools to assess oncologic risk and guide patient management and treatment planning. Current models are based on various ...

Identification of a Suitable Subgroup for Radiation Dose Escalation in Definitive Concurrent Chemoradiation Therapy for Nonmetastatic Esophageal Squamous Cell Carcinoma The median follow-up for ...

A peer-reviewed Harvard Medical School study recently published in Nature shows how a new artificial intelligence (AI) digital pathology tool called CHIEF (Clinical Histopathology Imaging Evaluation ...